1. About Materiovigilance Programme of India (MvPI)
The Materiovigilance Programme of India (MvPI) is an initiative of the Ministry of Health & Family Welfare, Government of India, coordinated by the Indian Pharmacopoeia Commission (IPC), Ghaziabad. The programme aims to monitor and analyse adverse events associated with medical devices, promote their safe use, encourage reporting by healthcare professionals, and enhance patient safety across the country
2. NIPER Hajipur under MvPI
NIPER Hajipur has been associated with the Materiovigilance Programme of India (MvPI) as a Medical Device Monitoring Centre (MDMC) since June 2022 and was subsequently recognized as a Regional Training Centre (RTC) in April 2023. In these capacities, the institute undertakes medical device adverse event monitoring and reporting, conducts sensitization programmes, training programmes and Continuing Medical Education (CME), promotes awareness regarding medical device safety, and provides technical support and capacity-building for healthcare professionals to strengthen the implementation of MvPI
3. Institutional Recognition
RTC Recognition Renewal (Valid: 13 April 2026 – 12 April 2029)
Appreciation Certificate received from the Indian Pharmacopoeia Commission (IPC) – 2025
If you experience any adverse event associated with medical devices Click Here for details
08 May 2026: A sensitization and training programme under the Materiovigilance Programme of India (MvPI) was organized by RTC–NIPER Hajipur at BIG Apollo Spectra Hospital, Patna, with the participation of 35 OT and CSSD professionals. The programme focused on medical device safety and Medical Device Adverse Event (MDAE) reporting
08 May 2026: A sensitization and training programme under the Materiovigilance Programme of India (MvPI) was organized by RTC–NIPER Hajipur at BIG Apollo Spectra Hospital, Patna, with the participation of 35 OT and CSSD professionals. The programme focused on medical device safety and Medical Device Adverse Event (MDAE) reporting
16, 19 & 20 January 2026: RTC–NIPER Hajipur conducted a 3-day Sensitization Programme under MvPI at Jay Prabha Medanta Hospital, Kankarbagh, Patna, with the participation of 210+ healthcare professionals. The programme enhanced awareness on medical device safety and strengthened Medical Device Adverse Event (MDAE) reporting practices across multiple departments.
16, 19 & 20 January 2026: RTC–NIPER Hajipur conducted a 3-day Sensitization Programme under MvPI at Jay Prabha Medanta Hospital, Kankarbagh, Patna, with the participation of 210+ healthcare professionals. The programme enhanced awareness on medical device safety and strengthened Medical Device Adverse Event (MDAE) reporting practices across multiple departments.
16, 19 & 20 January 2026: RTC–NIPER Hajipur conducted a 3-day Sensitization Programme under MvPI at Jay Prabha Medanta Hospital, Kankarbagh, Patna, with the participation of 210+ healthcare professionals. The programme enhanced awareness on medical device safety and strengthened Medical Device Adverse Event (MDAE) reporting practices across multiple departments.
05 January 2026: RTC–NIPER Hajipur conducted a Sensitization Session on the Overview of the Materiovigilance Programme of India (MvPI) at Sadar Hospital, Hajipur, with the participation of 60 healthcare professionals, including Medical Officers, nursing staff and representatives from 16 CHCs and PHCs. The programme enhanced awareness on medical device safety, clarified the importance of Medical Device Adverse Event (MDAE) reporting, and strengthened reporting practices to improve patient safety
05 January 2026: RTC–NIPER Hajipur conducted a Sensitization Session on the Overview of the Materiovigilance Programme of India (MvPI) at Sadar Hospital, Hajipur, with the participation of 60 healthcare professionals, including Medical Officers, nursing staff and representatives from 16 CHCs and PHCs. The programme enhanced awareness on medical device safety, clarified the importance of Medical Device Adverse Event (MDAE) reporting, and strengthened reporting practices to improve patient safety
